Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
2019; Massachusetts Medical Society; Volume: 382; Issue: 8 Linguagem: Inglês
10.1056/nejmoa1916433
ISSN1533-4406
AutoresBenjamin C. Blount, Mateusz P. Karwowski, Peter G. Shields, Maria Morel-Espinosa, Liza Valentín-Blasini, Michael Gardner, Martha Braselton, Christina R. Brosius, Kevin T. Caron, David M. Chambers, Joseph Corstvet, Elizabeth A. Cowan, Víctor R. De Jesús, Paul Espinosa, Carolina Fernández, Cory Holder, Zsuzsanna Kuklenyik, Jennifer D Kusovschi, Cody A. Newman, Gregory B. Reis, Jon Rees, C. C. Reese, Lalith Silva, Tiffany Seyler, Min‐Ae Song, Connie S. Sosnoff, Carleen R. Spitzer, Denise S. Tevis, Lanqing Wang, Cliff Watson, Mark D. Wewers, Baoyun Xia, Douglas T. Heitkemper, Isaac Ghinai, Jennifer E. Layden, Peter A. Briss, Brian A. King, Lisa Delaney, Christopher M. Jones, Grant Baldwin, Anita Patel, Dana Meaney‐Delman, Dale A. Rose, Vikram Krishnasamy, John R. Barr, Jerry Thomas, James L. Pirkle,
Tópico(s)Advanced Chemical Sensor Technologies
ResumoThe causative agents for the current national outbreak of electronic-cigarette, or vaping, product use–associated lung injury (EVALI) have not been established. Detection of toxicants in bronchoalveolar-lavage (BAL) fluid from patients with EVALI can provide direct information on exposure within the lung.
Referência(s)